Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.59 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20646201 | 0.87 | CYP1A2 (0.77) | CYP1A2CYP2C19CYP2C9IMPDH2IMPDH1 | |
| SCHEMBL23088434 | 0.87 | CYP1A2 (0.77) | CYP1A2CYP2C19CYP2C9SMN1; SMN2KMT2A | |
| SCHEMBL9823917 | 0.87 | CYP1A2 (0.77) | CYP1A2CYP2C19CYP2C9IMPDH2IMPDH1 | |
| SCHEMBL29792811 | 0.87 | CYP1A2 (0.77) | CYP1A2CYP2C19CYP2C9SMN1; SMN2KMT2A | |
| SCHEMBL14720795 | 0.86 | CYP1A2 (0.75) | CYP1A2CYP2C19CYP2C9IMPDH2IMPDH1 | |
| SCHEMBL19411114 | 0.86 | CYP1A2 (0.75) | CYP1A2CYP2C19CYP2C9IMPDH2IMPDH1 | |
| SCHEMBL13881965 | 0.86 | CYP2C9 (0.75) | CYP1A2CYP2C19CYP2C9SMN1; SMN2KMT2A | |
| SCHEMBL7871733 | 0.86 | CYP1A2 (0.75) | CYP1A2CYP2C19CYP2C9IMPDH2IMPDH1 | |
| SCHEMBL8102792 | 0.85 | CYP1A2 (0.73) | CYP1A2CYP2C19CYP2C9IMPDH2IMPDH1 | |
| SCHEMBL21167297 | 0.84 | CYP1A2 (0.73) | CYP1A2CYP2C19CYP2C9IMPDH2IMPDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3189030-B1 | 2,2' -DIAMINO BIARYLS WITH TWO SECONDARY AMINES AND PRODUCTION THEREOF BY ELECTROCHEMICAL COUPLING | EVONIK DEGUSSA GMBH (DE) | 2019-05-01 | — | — | EP | disclosed |
| US-10196747-B2 | 2,2′-diaminobiaryls having two secondary amines | EVONIK DEGUSSA GMBH (DE) | 2019-02-05 | — | — | US | disclosed |
| US-10131628-B2 | 2,2′-diaminobiaryls having a phthaloyl group or succinoyl group | EVONIK DEGUSSA GMBH (DE) | 2018-11-20 | — | — | US | disclosed |
| US-10125093-B2 | 2,2′-diaminobiaryls having one primary and one secondary amine | EVONIK DEGUSSA GMBH (DE) | 2018-11-13 | — | — | US | disclosed |
| US-20170305846-A1 | 2,2' -DIAMINOBIARYLS HAVING A PHTHALOYL GROUP OR SUCCINOYL GROUP | EVONIK DEGUSSA GMBH (DE) | 2017-10-26 | — | — | US | disclosed |
| US-20170298013-A1 | 2,2' -DIAMINO BIARYLS WITH TWO SECONDARY AMINES AND PRODUCTION THEREOF BY ELECTROCHEMICAL COUPLING | EVONIK DEGUSSA GMBH (DE) | 2017-10-19 | — | — | US | disclosed |
| US-20170291871-A1 | 2,2' -DIAMINOBIARYLS HAVING ONE PRIMARY AND ONE SECONDARY AMINE | EVONIK DEGUSSA GMBH (DE) | 2017-10-12 | — | — | US | disclosed |
| US-20170283961-A1 | 2,2' -DIAMINOBIARYLS HAVING TWO SECONDARY AMINES | EVONIK DEGUSSA GMBH (DE) | 2017-10-05 | — | — | US | disclosed |
| EP-3189031-A1 | 2,2' -DIAMINO BIARYLS WITH A PRIMARY AND A SECONDARY AMINE AND PRODUCTION THEREOF BY ELECTROCHEMICAL COUPLING | Evonik Degussa GmbH (DE) | 2017-07-12 | — | — | EP | disclosed |
| EP-3189034-A1 | 2,2'-DIAMINO BIARYLS WITH PHTHALOYL-GROUPS OR SUCCINOYL-GROUPS | Evonik Degussa GmbH (DE) | 2017-07-12 | — | — | EP | disclosed |
| EP-3189032-A1 | NOVEL 2,2' -DIAMINO BIARYLS WITH TWO SECONDARY AMINES AND PRODUCTION THEREOF BY ELECTROCHEMICAL COUPLING | Evonik Degussa GmbH (DE) | 2017-07-12 | — | — | EP | disclosed |
| EP-3189030-A1 | 2,2' -DIAMINO BIARYLS WITH TWO SECONDARY AMINES AND PRODUCTION THEREOF BY ELECTROCHEMICAL COUPLING | Evonik Degussa GmbH (DE) | 2017-07-12 | — | — | EP | disclosed |
| CN-106604910-A | 2, 2-diaminobiaryls with two secondary amines and their preparation by electrochemical coupling | 赢创德固赛有限公司 | 2017-04-26 | — | — | CN | disclosed |
| WO-2016034327-A1 | 2,2' -DIAMINO BIARYLS WITH TWO SECONDARY AMINES AND PRODUCTION THEREOF BY ELECTROCHEMICAL COUPLING | EVONIK DEGUSSA GMBH (DE) | 2016-03-10 | — | — | WO | disclosed |
| WO-2016034330-A1 | NOVEL 2,2' -DIAMINO BIARYLS WITH TWO SECONDARY AMINES AND PRODUCTION THEREOF BY ELECTROCHEMICAL COUPLING | EVONIK DEGUSSA GMBH (DE) | 2016-03-10 | — | — | WO | disclosed |
| WO-2016034328-A1 | 2,2' -DIAMINO BIARYLS WITH A PRIMARY AND A SECONDARY AMINE AND PRODUCTION THEREOF BY ELECTROCHEMICAL COUPLING | EVONIK DEGUSSA GMBH (DE) | 2016-03-10 | — | — | WO | disclosed |
| WO-2016034332-A1 | 2,2'-DIAMINO BIARYLS WITH PHTHALOYL-GROUPS OR SUCCINOYL-GROUPS | EVONIK DEGUSSA GMBH (DE) | 2016-03-10 | — | — | WO | disclosed |
| EP-2114869-A1 | RHO KINASE INHIBITORS | Boehringer Ingelheim International GmbH (DE) | 2009-11-11 | — | — | EP | disclosed |
| WO-2008086047-A1 | RHO KINASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10125093-B2 | 2,2′-diaminobiaryls having one primary and one secondary amine | SAT1, AOC1, DDT | CYP1A2 2142/4885CYP2C19 3236/4885CYP2C9 3705/4885 |
| US-20170298013-A1 | 2,2' -DIAMINO BIARYLS WITH TWO SECONDARY AMINES AND PRODUCTION THEREOF BY ELECTROCHEMICAL COUPLING | PM20D2, XDH, DAO | CYP1A2 44/4885CYP2C19 395/4885CYP2C9 239/4885 |
| US-20170291871-A1 | 2,2' -DIAMINOBIARYLS HAVING ONE PRIMARY AND ONE SECONDARY AMINE | SAT1, AOC1, DDT | CYP1A2 2083/4885CYP2C19 3254/4885CYP2C9 3680/4885 |
| US-20170283961-A1 | 2,2' -DIAMINOBIARYLS HAVING TWO SECONDARY AMINES | AOC1, DDT, DDC | CYP1A2 1324/4885CYP2C19 2705/4885CYP2C9 2919/4885 |
| US-20170305846-A1 | 2,2' -DIAMINOBIARYLS HAVING A PHTHALOYL GROUP OR SUCCINOYL GROUP | SUCLA2, SPATS2L, SUCLG2 | CYP1A2 3692/4885CYP2C19 3640/4885CYP2C9 3517/4885 |
| US-10131628-B2 | 2,2′-diaminobiaryls having a phthaloyl group or succinoyl group | DDC, PNMT, INMT | CYP1A2 1332/4885CYP2C19 2102/4885CYP2C9 1683/4885 |
| US-10196747-B2 | 2,2′-diaminobiaryls having two secondary amines | AOC1, DDT, DDC | CYP1A2 1412/4885CYP2C19 2737/4885CYP2C9 2984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.